Research & Innovation
Publications
HDAC Class I Inhibitor Romidepsin as a novel and promising Epigenetic Drug for Biliary Tract Cancer.
PMU Authors
Christian Reinhard Mayr, Tobias Kiesslich, Dino Bekric, Heidemarie Dobias, Markus Ritter, Tarkan Jäger, Eckhard Klieser, Daniel Neureiter
All Authors
Christian Reinhard Mayr, Tobias Kiesslich, S. Erber, Dino Bekric, Heidemarie Dobias, Markus Ritter, Tarkan Jäger, Neumayer, Eckhard Klieser, Daniel Neureiter
Abstract
We are sorry. The full text is not available.